Mark Mallon, Chief Executive Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 61,350 shares at $9.11 ($559K) on 2021-02-26, disclosed to the SEC on 2021-03-02.
Open-market sale of $559k IRWD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.11 | 8,093 | $74K | 13.2% |
| 2 | $9.11 | 8,093 | $74K | 13.2% |
| 3 | $9.11 | 22,582 | $206K | 36.8% |
| 4 | $9.11 | 22,582 | $206K | 36.8% |
| Total | $9.11 avg | 61,350 | $559K | 100% |
| Filing → |
| IRWD | SELL | 2020-02-25 | $186K | — | Filing → |